Clinical Utility of Neuromodulation on Tinnitus

Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan26 enrolled

Overview

The aim of the present narrative review is to one of the first to critically evaluate the clinical effectiveness of neuromodulation as a therapeutic option for patients with tinnitus. Our method involves conducting a systemic review and the findings reported following PRISMA statement. Pubmed, Cochrane database and Google Scholar databases literature search was conducted for articles reporting the use of neuromodulatory interventions on tinnitus patients. Each article was evaluated using the Cochrane risk of bias tool.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Tinnitus

Eligibility

Sex: ALLMin age: 18 YearsMax age: 65 Years

Medical Language ↔ Plain English

Inclusion Criteria: * Tinnitus patients * At least one of the neurofeedback methods * Single and multi-center * Randomized control trials and observational studies Exclusion Criteria: * Non-peer-reviewed papers, letters, editorials * Not English language

Locations (1)

Hearing and Language Healthcare Center, China Medical University Hsinchu Hospital, Taiwan

Hsinchu, Taiwan

Outcomes

Primary Outcomes

Tinnitus severity scores

Time frame: 9 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.